By Max Mitchell | July 18, 2017
Pharmaceutical companies facing more than 100 lawsuits in federal court over improperly labeled birth control pills want the plaintiffs to provide pre-discovery information linking their claimed injuries to the defendants' products.
By Amanda Bronstad | July 18, 2017
A newly available transcript from St. Louis Civil Court shows just how quickly the U.S. Supreme Court's game-changing decision in Bristol-Myers Squibb v. Superior Court of California transformed a Missouri case over the alleged link between talcum powder and cancer.
By Amanda Bronstad | July 12, 2017
Plaintiffs lawyers hoping to revive 3,128 lawsuits over cholesterol drug Lipitor are asking an appeals court to overturn what they consider to be a heightened standard on expert evidence that could hasten the demise of other multidistrict litigation.
By Michael Booth | July 5, 2017
A New Jersey appeals court has reinstated a products liability claim against BMW of America by a vehicle owner alleging he burned his leg on an exhaust pipe that extended beyond the rear bumper.
By Charles Toutant | June 22, 2017
Lawyers handling drug-defect suits say New Jersey courts could see an uptick in volume of pharmaceutical and medical device suits in light of this week's Supreme Court ruling in a California case that narrowed access to jurisdiction for out-of-state plaintiffs.
By njlawjournal | New Jersey Law Journal | June 5, 2017
The products liability group at McCarter & English of Newark last year represented some big-name clients in high-leverage matters. In one case, the…
By Max Mitchell | June 2, 2017
The U.S. Court of Appeals for the Third Circuit has rejected attempts to revive 315 scuttled cases against Pfizer over claims that its anxiety medication Zoloft caused birth defects.
By Max Mitchell | May 30, 2017
Plaintiffs suing Merck over its shingles vaccine Zostavax have lost the fight to have their cases heard in state court, after a judge determined one defendants was fraudulently joined.
By Amanda Bronstad | May 10, 2017
On Wednesday, Armstrong Teasdale partner Thomas Weaver asked the Missouri Court of Appeals to reverse a $72 million award—one of four hefty verdicts against Johnson & Johnson cases linking its baby powder to ovarian cancer.
By Amanda Bronstad | May 4, 2017
In five trials over the safety of its talcum powder, Johnson & Johnson has racked up four losses. Thursday's verdict from a Missouri jury was the biggest blow so far.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
With bold growth in recent years, Fox Rothschild brings together 1,000 attorneys coast to coast. We offer the reach and resources of a natio...
About Us:Monjur.com is a leading provider of contracts-as-a-service for managed service providers, offering tailored solutions to streamline...
Dynamic Boutique law firm with offices in NYC, Westchester County and Dutchess County, is seeking a mid level litigation associate to work ...